European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478- [portable]

Monograph 0478 outlines several physical and chemical tests designed to ensure that the tablet performs as intended once ingested.

For a pharmaceutical professional, mastering is non-negotiable. Whether you are submitting a Section 10.2 dossier to an EU reference member state, performing QC release testing in a GMP lab, or formulating a new generic, every decision must ultimately answer one question: Does this comply with Ph. Eur. Monograph 0478?

Monograph 0478 is not a drug-specific monograph (like Paracetamol Tablets ). Instead, it is a . General monographs apply to all articles of a given type. Therefore, whether you are manufacturing a 500 mg antibiotic tablet or a 25 mg antihistamine tablet, the requirements set forth in Ph. Eur. 0478 are automatically applicable, unless a specific individual monograph overrides a particular test. European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

While not exclusive to tablets, explicitly demands compliance with:

For a QC analyst, the workflow for testing "Tablets" against follows a logical sequence. Failure at any step triggers an OOS (Out of Specification) investigation. Monograph 0478 outlines several physical and chemical tests

This monograph (01/2008:0478) is a , meaning its requirements apply to all individual tablet monographs unless otherwise stated.

Before diving into tests, the monograph defines its scope. According to , a tablet is a solid dosage form manufactured by compressing a single batch of powder or granules. The monograph explicitly covers: Instead, it is a

: Not more than one individual mass can be outside 85–115% of the average mass; it fails if more than one is outside these limits or if any are outside 75–125%. Disintegration